Diabetes

The Pharmacy Times® Diabetes Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of chronic diseases that result in high blood glucose.

FDA Accepts Aflibercept sBLA for Treatment of Diabetic Retinopathy

July 03, 2022

Article

If approved, the 16-week dosing regimen could offer certain individuals a potentially longer treatment interval and physicians with greater flexibility to individualize treatment.

Daily Medication Pearl: Semaglutide (Wegovy)

June 29, 2022

Article

Semaglutide (Wegovy) is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients.

Pharmacy Focus Podcast Episode 49: Inpatient Insulin Management from the Pharmacy Perspective

June 24, 2022

Podcast

Stephanie Mason believes that pharmacists should expect their involvement in glycemic management to increase in the near future.

Calling Them “Vanity Drugs,” Some Insurers Refuse to Cover New Anti-Obesity Drugs

June 23, 2022

Video

Insurers are refusing to cover new, highly effective anti-obesity drugs, but some prescribers are getting around the issue.

Shine a Light on Diabetes and Mental Health

June 21, 2022

Article

Appropriate screening tools can help identify individuals at increased risk for or with anxiety, depression, and eating disorders.

Clinical Overview: Tirzepatide (Mounjaro) for Type 2 Diabetes Mellitus

June 21, 2022

Article

Tirzepatide is a dual receptor agonist, acting on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 to lower blood glucose levels.

Daily Medication Pearl: Naltrexone HCl and Bupropion HCl (Contrave)

June 20, 2022

Article

Contrave is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.

Daily Medication Pearl: Saxagliptin/Metformin (Kombiglyze)

June 13, 2022

Article

Kombiglyze is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Arterial Stiffness May Predict Type 2 Diabetes Risk Better Than Blood Pressure, Standard Risk Factors

June 03, 2022

Article

Individuals with elevated arterial stiffness combined with high blood pressure had the highest risk of developing type 2 diabetes.

FDA Clears FreeStyle Libre 3 System For Use by Individuals 4 Years and Older With Diabetes

May 31, 2022

Article

The FreeStyle Libre 3 is the most accurate 14-day continuous glucose monitor with a 7.9% overall mean absolute relative difference and readings are sent directly to a smartphone every minute.